{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:26:27Z","timestamp":1743740787894,"version":"3.40.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-025-08557-4","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T22:22:35Z","timestamp":1743718955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Orthopedic surgical treatment of osteomalacia induced by culprit soft tissue tumor in the hip region: a single-center retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuzhong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"1","key":"8557_CR1","first-page":"33","volume":"16","author":"RA McCANCE","year":"1947","unstructured":"McCANCE RA. Osteomalacia with looser\u2019s nodes (Milkman\u2019s syndrome) due to a Raised resistance to vitamin D acquired about the age of 15 years. Q J Med. 1947;16(1):33\u201346.","journal-title":"Q J Med"},{"issue":"9","key":"8557_CR2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Min Res. 2012;27(9):1967\u201375.","journal-title":"J Bone Min Res"},{"issue":"7","key":"8557_CR3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","volume":"64","author":"J Feng","year":"2017","unstructured":"Feng J, Jiang Y, Wang O, et al. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J. 2017;64(7):675\u201383.","journal-title":"Endocr J"},{"issue":"4","key":"8557_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.afos.2018.12.001","volume":"4","author":"Z Yin","year":"2018","unstructured":"Yin Z, Du J, Yu F, et al. Tumor-induced osteomalacia. Osteoporos Sarcopenia. 2018;4(4):119\u201327.","journal-title":"Osteoporos Sarcopenia"},{"issue":"3","key":"8557_CR5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00774-016-0756-9","volume":"35","author":"WJ Yu","year":"2017","unstructured":"Yu WJ, He JW, Fu WZ, et al. Reports of 17 Chinese patients with tumor-induced osteomalacia. J Bone Min Metab. 2017;35(3):298\u2013307.","journal-title":"J Bone Min Metab"},{"issue":"9","key":"8557_CR6","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00198-022-06432-9","volume":"33","author":"S Minisola","year":"2022","unstructured":"Minisola S, Barlassina A, Vincent SA, et al. A literature review to understand the burden of disease in people living with tumour-induced osteomalacia. Osteoporos Int. 2022;33(9):1845\u201357.","journal-title":"Osteoporos Int"},{"issue":"4","key":"8557_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00223-022-01005-8","volume":"111","author":"A Bosman","year":"2022","unstructured":"Bosman A, Palermo A, Vanderhulst J, De Beur SMJ, Fukumoto S, Minisola S, Xia W, Body JJ, Zillikens MC. Tumor-Induced osteomalacia: A systematic clinical review of 895 cases. Calcif Tissue Int. 2022;111(4):367\u201379. https:\/\/doi.org\/10.1007\/s00223-022-01005-8. Epub 2022 Jul 20. PMID: 35857061; PMCID: PMC9474374.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"8557_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/jcm12010252","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, He H, Zhang C, Zeng H, Tong X, Liu Q. Phosphaturic mesenchymal tumors: rethinking the clinical diagnosis and surgical treatment. J Clin Med. 2022;12(1):252. https:\/\/doi.org\/10.3390\/jcm12010252. PMID: 36615052; PMCID: PMC9821698.","journal-title":"J Clin Med"},{"key":"8557_CR9","doi-asserted-by":"publisher","unstructured":"Rendina D, Abate V, Cacace G, D\u2019Elia L, De Filippo G, Del Vecchio S, Galletti F, Cuocolo A, Strazzullo P. Tumor-induced Osteomalacia: A Systematic Review and Individual Patient\u2019s Data Analysis. J Clin Endocrinol Metab. 2022;107(8):e3428-e3436. https:\/\/doi.org\/10.1210\/clinem\/dgac253. PMID: 35468192.","DOI":"10.1210\/clinem\/dgac253"},{"key":"8557_CR10","doi-asserted-by":"publisher","unstructured":"Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV. Tumor-induced Osteomalacia: A Comprehensive Review. Endocr Rev. 2023;44(2):323\u2013353. https:\/\/doi.org\/10.1210\/endrev\/bnac026. PMID: 36327295.","DOI":"10.1210\/endrev\/bnac026"},{"key":"8557_CR11","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.bonr.2018.100192","volume":"10","author":"Y Kinoshita","year":"2019","unstructured":"Kinoshita Y, Takashi Y, Ito N, et al. Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23) -producing tumors that cause tumor-induced rickets \/osteomalacia (TIO) [J]. Bone Rep. 2019;10:100192.","journal-title":"Bone Rep"},{"issue":"3","key":"8557_CR12","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Andreopoulou P, Chen CC, et al. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18(3):R53\u201377.","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"8557_CR13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrendo.2009.196","volume":"5","author":"MS Razzaque","year":"2009","unstructured":"Razzaque MS. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol. 2009;5(11):611\u20139.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"8557_CR14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/039139880903200407","volume":"32","author":"G Tsagalis","year":"2009","unstructured":"Tsagalis G, Psimenou E, Manios E, et al. Fibroblast growth factor 23 (FGF23) and the kidney. Int J Artif Organs. 2009;32(4):232\u20139.","journal-title":"Int J Artif Organs"},{"issue":"12","key":"8557_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2012.07.002","volume":"23","author":"N Bhattacharyya","year":"2012","unstructured":"Bhattacharyya N, Chong WH, Gafni RI, et al. Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab. 2012;23(12):610\u20138.","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"8557_CR16","doi-asserted-by":"publisher","first-page":"8369","DOI":"10.1007\/s13277-014-2102-y","volume":"35","author":"F Lococo","year":"2014","unstructured":"Lococo F, Cesario A, Paci M, Filice A, Versari A, Rapicetta C, Ricchetti T, Sgarbi G, Alifano M, Cavazza A, Treglia G. PET\/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol. 2014;35(9):8369\u201377. https:\/\/doi.org\/10.1007\/s13277-014-2102-y. Epub 2014 May 22. PMID: 24850179.","journal-title":"Tumour Biol"},{"key":"8557_CR17","doi-asserted-by":"publisher","unstructured":"Wang P, Zhang S, Huo L, Jing H, Li F. Prognostic Value of Positive Presurgical FDG PET\/CT in the Evaluation of Tumor-Induced Osteomalacia. Clin Nucl Med. 2021;46(3):214\u2013219. https:\/\/doi.org\/10.1097\/RLU.0000000000003463. PMID: 33351512.","DOI":"10.1097\/RLU.0000000000003463"},{"key":"8557_CR18","doi-asserted-by":"publisher","first-page":"811209","DOI":"10.3389\/fonc.2022.811209","volume":"12","author":"G Hou","year":"2022","unstructured":"Hou G, Zhang Y, Liu Y, Wang P, Xia W, Xing X, Huo L, Li F, Jing H. Head-to-Head comparison of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET\/CT in patients with Tumor-Induced osteomalacia: A prospective study. Front Oncol. 2022;12:811209. https:\/\/doi.org\/10.3389\/fonc.2022.811209. PMID: 35280786; PMCID: PMC8913035.","journal-title":"Front Oncol"},{"issue":"3","key":"8557_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12149-021-01575-x","volume":"35","author":"A Kato","year":"2021","unstructured":"Kato A, Nakamoto Y, Ishimori T, Hayakawa N, Ueda M, Temma T, Sano K, Shimizu Y, Saga T, Togashi K. Diagnostic performance of 68Ga-DOTATOC PET\/CT in tumor-induced osteomalacia. Ann Nucl Med. 2021;35(3):397\u2013405. Epub 2021 Feb 13. PMID: 33582980.","journal-title":"Ann Nucl Med"},{"key":"8557_CR20","doi-asserted-by":"publisher","unstructured":"Sekine T, Barbosa FG, Sah BR, Mader CE, Delso G, Burger IA, Stolzmann P, Ter Voert EE, von Schulthess GK, Veit-Haibach P, Huellner MW. PET\/MR Outperforms PET\/CT in Suspected Occult Tumors. Clin Nucl Med. 2017;42(2):e88-e95. https:\/\/doi.org\/10.1097\/RLU.0000000000001461. PMID: 27922861.","DOI":"10.1097\/RLU.0000000000001461"},{"issue":"4","key":"8557_CR21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MNM.0000000000001163","volume":"41","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Hou G, Cheng W. Performance of 68Ga-DOTA-SST PET\/CT, Octreoscan SPECT\/CT and 18F-FDG PET\/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis. Nucl Med Commun. 2020;41(4):370\u20136. PMID: 32000173; PMCID: PMC7077972.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"8557_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/joim.13593","volume":"293","author":"SM Jan de Beur","year":"2023","unstructured":"Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton-Bligh R, Collins M, Florenzano P, Houillier P, Imanishi Y, Imel EA, Khan AA, Zillikens MC, Fukumoto S. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med. 2023;293(3):309\u201328. https:\/\/doi.org\/10.1111\/joim.13593. Epub 2022 Dec 13. PMID: 36511653; PMCID: PMC10108006.","journal-title":"J Intern Med"},{"issue":"12","key":"8557_CR23","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00264-017-3610-3","volume":"41","author":"H Kobayashi","year":"2017","unstructured":"Kobayashi H, Ito N, Akiyama T, et al. Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia. Int Orthop. 2017;41(12):2597\u2013603.","journal-title":"Int Orthop"},{"issue":"1","key":"8557_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1):1\u201330.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"8557_CR25","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","volume":"59","author":"DJ Evans","year":"1987","unstructured":"Evans DJ, Azzopardi JG. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59(8):1442\u201354.","journal-title":"Cancer"},{"issue":"6","key":"8557_CR26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s13139-018-0546-5","volume":"52","author":"S Ha","year":"2018","unstructured":"Ha S, Park S, Kim H, Go H, Lee SH, Choi JY, Hong JY, Ryu JS. Successful localization using 68Ga-DOTATOC PET\/CT of a phosphaturic mesenchymal tumor causing osteomalacia in a patient with concurrent follicular lymphoma. Nucl Med Mol Imaging. 2018;52(6):462\u20137. Epub 2018 Sep 12. PMID: 30538778; PMCID: PMC6261860.","journal-title":"Nucl Med Mol Imaging"},{"issue":"10","key":"8557_CR27","doi-asserted-by":"publisher","first-page":"omx045","DOI":"10.1093\/omcr\/omx045","volume":"2017","author":"L Tonello","year":"2017","unstructured":"Tonello L, Gatti AP, Neto JD, Teixeira UF, Bertozzi Goldoni M, Fontes PRO, Sampaio JA, Lima LMP, Waechter FL. A case of oncogenic osteomalacia owing to inguinal tumor. Oxf Med Case Rep. 2017;2017(10):omx045. https:\/\/doi.org\/10.1093\/omcr\/omx045. PMID: 29744113; PMCID: PMC5934660.","journal-title":"Oxf Med Case Rep"},{"key":"8557_CR28","doi-asserted-by":"publisher","unstructured":"Takeuchi Y, Suzuki H, Ogura S, Imai R, Yamazaki Y, Yamashita T, Miyamoto Y, Okazaki H, Nakamura K, Nakahara K, Fukumoto S, Fujita T. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab. 2004;89(8):3979-82. https:\/\/doi.org\/10.1210\/jc.2004-0406. PMID: 15292336.","DOI":"10.1210\/jc.2004-0406"},{"issue":"12","key":"8557_CR29","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00264-017-3610-3","volume":"41","author":"H Kobayashi","year":"2017","unstructured":"Kobayashi H, Ito N, Akiyama T, Okuma T, Kinoshita Y, Ikegami M, Shinoda Y, Fukumoto S, Tanaka S, Kawano H. Prevalence and clinical outcomes of hip fractures and subchondral insufficiency fractures of the femoral head in patients with tumour-induced osteomalacia. Int Orthop. 2017;41(12):2597\u2013603. https:\/\/doi.org\/10.1007\/s00264-017-3610-3. Epub 2017 Aug 23. PMID: 28836028.","journal-title":"Int Orthop"},{"key":"8557_CR30","doi-asserted-by":"publisher","unstructured":"Chouhan V, Agrawal K, Vinothkumar TK, Mathesul A. Bilateral insufficiency fracture of the femoral head and neck in a case of oncogenic osteomalacia. J Bone Joint Surg Br. 2010;92(7):1028-31. https:\/\/doi.org\/10.1302\/0301-620X.92B7.24526. PMID: 20595128.","DOI":"10.1302\/0301-620X.92B7.24526"},{"issue":"11","key":"8557_CR31","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/CM9.0000000000001448","volume":"134","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Li X, Huo L, Liu Y, Lyu W, Zhou L, Yu W, Wu HW, Xing XP, Li M, Wang O, Chi Y, Jiajue RZ, Pei Y, Liu JM, Ba JM, Zhang Q, Sheng ZF, Zhang ZL, Zhao JJ, Minisola S, Xia WB. Chinese society of osteoporosis and bone mineral research and Chinese society of endocrinology. Consensus on clinical management of tumor-induced osteomalacia. Chin Med J (Engl). 2021;134(11):1264\u20136. https:\/\/doi.org\/10.1097\/CM9.0000000000001448. PMID: 33813513; PMCID: PMC8183716.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"8557_CR32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00223-015-0029-y","volume":"98","author":"S Fukumoto","year":"2016","unstructured":"Fukumoto S. FGF23-FGF receptor\/klotho pathway as a new drug target for disorders of bone and mineral metabolism. Calcif Tissue Int. 2016;98(4):334\u201340.","journal-title":"Calcif Tissue Int"},{"key":"8557_CR33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semcdb.2015.10.012","volume":"53","author":"Y Tanner","year":"2016","unstructured":"Tanner Y, Grose RP. Dysregulated FGF signalling in neoplastic disorders. Semin Cell Dev Biol. 2016;53:126\u201335.","journal-title":"Semin Cell Dev Biol"},{"key":"8557_CR34","doi-asserted-by":"crossref","unstructured":"Gandhi GY, Shah AA, Wu KJ et al. Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report. Case Rep Endocrinol, 2012, 2012:185454.","DOI":"10.1155\/2012\/185454"},{"issue":"3","key":"8557_CR35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.3903","volume":"35","author":"X Li","year":"2020","unstructured":"Li X, Jiang Y, Huo L, Wu H, Liu Y, Jin J, Yu W, Lv W, Zhou L, Xia Y, Wang O, Li M, Xing X, Chi Y, Jiajue R, Cui L, Meng X, Xia W. Nonremission and recurrent Tumor-Induced osteomalacia: A retrospective study. J Bone Min Res. 2020;35(3):469\u201377. Epub 2019 Nov 15. PMID: 31643101; PMCID: PMC7140180.","journal-title":"J Bone Min Res"},{"issue":"3","key":"8557_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/joim.13593","volume":"293","author":"SM Jan de Beur","year":"2023","unstructured":"Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton-Bligh R, Collins M, Florenzano P, Houillier P, Imanishi Y, Imel EA, Khan AA, Zillikens MC, Fukumoto S. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med. 2023;293(3):309\u201328. https:\/\/doi.org\/10.1111\/joim.13593. Epub 2022 Dec 13. PMID: 36511653.","journal-title":"J Intern Med"},{"issue":"7","key":"8557_CR37","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00198-020-05369-1","volume":"31","author":"L Colangelo","year":"2020","unstructured":"Colangelo L, Pepe J, Nieddu L, et al. Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia. Osteoporos Int. 2020;31(7):1383\u20137.","journal-title":"Osteoporos Int"},{"issue":"7","key":"8557_CR38","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4103\/ija.IJA_57_17","volume":"61","author":"A Verma","year":"2017","unstructured":"Verma A, Tewari S, Kannaujia A. Perioperative management of patients with severe hypophosphataemia secondary to oncogenic osteomalacia: our experience and review of literature. Indian J Anaesth. 2017;61(7):590\u20133. https:\/\/doi.org\/10.4103\/ija.IJA_57_17. PMID: 28794533; PMCID: PMC5530746.","journal-title":"Indian J Anaesth"},{"key":"8557_CR39","doi-asserted-by":"publisher","unstructured":"Ni X, Feng Y, Guan W, Chi Y, Li X, Gong Y, Zhao N, Pang Q, Yu W, Wu H, Huo L, Liu Y, Jin J, Zhou X, Lv W, Zhou L, Xia Y, Liu W, Jiajue R, Wang O, Li M, Xing X, Fukumoto S, Jiang Y, Xia W. Bone Impairment in a Large Cohort of Chinese Patients With Tumor-Induced Osteomalacia Assessed by HR-pQCT and TBS. J Bone Miner Res. 2022;37(3):454\u2013464. https:\/\/doi.org\/10.1002\/jbmr.4476. Epub 2022 Jan 3. PMID: 34796540.","DOI":"10.1002\/jbmr.4476"},{"issue":"9","key":"8557_CR40","doi-asserted-by":"publisher","first-page":"bvab099","DOI":"10.1210\/jendso\/bvab099","volume":"5","author":"K Dahir","year":"2021","unstructured":"Dahir K, Zanchetta MB, Stanciu I, Robinson C, Lee JY, Dhaliwal R, Charles J, Civitelli R, Roberts MS, Krolczyk S, Weber T. Diagnosis and management of Tumor-induced osteomalacia: perspectives from clinical experience. J Endocr Soc. 2021;5(9):bvab099. https:\/\/doi.org\/10.1210\/jendso\/bvab099. PMID: 34286168; PMCID: PMC8282217.","journal-title":"J Endocr Soc"},{"key":"8557_CR41","doi-asserted-by":"publisher","first-page":"100600","DOI":"10.1016\/j.jbo.2024.100600","volume":"45","author":"S Liu","year":"2024","unstructured":"Liu S, Zhou X, Liu Y, Zhang J, Xia W. Preoperative evaluation and orthopedic surgical strategies for tumor-induced osteomalacia. J Bone Oncol. 2024;45:100600. https:\/\/doi.org\/10.1016\/j.jbo.2024.100600. PMID: 38577550; PMCID: PMC10990903.","journal-title":"J Bone Oncol"},{"issue":"9","key":"8557_CR42","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00198-020-05795-1","volume":"32","author":"JC Horng","year":"2021","unstructured":"Horng JC, Van Eperen E, Tutton S, Singh R, Shaker JL, Wooldridge AN. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation. Osteoporos Int. 2021;32(9):1895\u20138. https:\/\/doi.org\/10.1007\/s00198-020-05795-1. Epub 2021 Mar 2. PMID: 33655402.","journal-title":"Osteoporos Int"},{"issue":"7","key":"8557_CR43","doi-asserted-by":"publisher","first-page":"e10178","DOI":"10.1002\/jbm4.10178","volume":"3","author":"SK Mishra","year":"2019","unstructured":"Mishra SK, Kuchay MS, Sen IB, Garg A, Baijal SS, Mithal A. Successful management of Tumor-Induced osteomalacia with radiofrequency ablation: A case series. JBMR Plus. 2019;3(7):e10178. https:\/\/doi.org\/10.1002\/jbm4.10178. PMID: 31372587; PMCID: PMC6659451.","journal-title":"JBMR Plus"},{"key":"8557_CR44","doi-asserted-by":"publisher","unstructured":"Fukumoto S. FGF23-related hypophosphatemic rickets\/osteomalacia: diagnosis and new treatment. J Mol Endocrinol. 2021;66(2):R57-R65. https:\/\/doi.org\/10.1530\/JME-20-0089. PMID: 33295878.","DOI":"10.1530\/JME-20-0089"},{"key":"8557_CR45","doi-asserted-by":"publisher","unstructured":"Li X, Gong Y, Zhang Q, Ni X, Pang Q, Chi Y, Jiajue R, Cui L, Jiang X, Wang O, Xing X, Jiang Y, Li M, Xia W. Ultra-High Performance Liquid Chromatography-Mass Spectrometry-based Serum Metabolomics for Early Diagnosis of Refractory Tumor-induced Osteomalacia: A Case-control Study. J Clin Endocrinol Metab. 2023;108(8):2016\u20132023. https:\/\/doi.org\/10.1210\/clinem\/dgad034. PMID: 36718510.","DOI":"10.1210\/clinem\/dgad034"},{"issue":"3","key":"8557_CR46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12020-022-03039-2","volume":"76","author":"L Cianferotti","year":"2022","unstructured":"Cianferotti L, Delli Poggi C, Bertoldo F, Caffarelli C, Crotti C, Gatti D, Giannini S, Gonnelli S, Mazzantini M, Ombretta V, Sella S, Setti A, Varenna M, Zucchi F, Brandi ML. Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a National survey\/case series. Endocrine. 2022;76(3):709\u201321. Epub 2022 Apr 5. PMID: 35381903; PMCID: PMC9156492.","journal-title":"Endocrine"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08557-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-08557-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-08557-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T22:23:43Z","timestamp":1743719023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-08557-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8557"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-08557-4","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking Union Medical College Hospital (approval number S-K1658). This study was conducted in accordance with the principles of the Declaration of Helsinki. All data were anonymized, and the requirement for informed consent was waived by the Institutional Review Board due to the retrospective nature of the study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}